You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Amgen to collab with Verastem on KRAS combination treatment

Amgen and Versatem Oncology have announced a new clinical collaboration agreement to evaluate a combination treatment in KRAS G12C-mutant non-small cell lung cancer (NSCLC).